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BACKGROUND: Human embryonic stem cell (hESC) lines derived from poor quality embryos usually have either
normal or abnormal karyotypes. However, it is still unclear whether their biological characteristics are similar.
METHODS: Seven new hESC lines were established using discarded embryos. Five cell lines had normal karyotype,
one was with an unbalanced Robertsonian translocation and one had a triploid karyotype. Their biological character-
istics, short tandem repeat loci, HLA typing, differentiation capability and imprinted gene, DNA methylation and
X chromosome inactivation status were compared between different cell lines. RESULTS: All seven hESC lines
had similar biological characteristics regardless of karyotype (ﬁve normal and two abnormal), such as expression
of stage-speciﬁc embryonic antigen (SSEA)-4, tumor-rejection antigen (TRA)-1-81 and TRA-1-60 proteins, transcrip-
tion factor octamer binding protein 4 mRNA, no detectable expression of SSEA-1 protein and high levels of alkaline
phosphatase activity. All cell lines were able to undergo differentiation. Imprinted gene expression and DNA methyl-
ation were also similar among these cell lines. Non-random X chromosome inactivation patterns were found in XX cell
lines. CONCLUSIONS: The present results suggest that hESC lines with abnormal karyotype are also useful exper-
imental materials for cell therapy, developmental biology and genetic research.
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Introduction
Human embryonic stem cell (hESC) research is one of the most
rapidly growing areas in cell biology and medicine. Recent evi-
dence has indicated that hESC can be cultured in the labora-
tory, unlimitedly passed from generation to generation
(Thomson et al., 1998; Stojkovic et al., 2004; Oh et al.,
2005; Peura et al., 2007) and induced to differentiate into all
kinds of somatic cells under appropriate conditions. These dif-
ferentiated cells can be used to restore damaged tissues and to
treat some kinds of diseases (Assady et al., 2001; Kehat et al.,
2001; Wang et al., 2005; Lim et al., 2006).
Since the ﬁrst hESC line was established in 1998 (Thomson
et al., 1998), more than 400 hESC lines have been established
in 20 countries and some of them have been registered in the
National Institutes of Health (http:escr.nih.gov/) (Guhr et al.,
2006). To establish new hESC lines, human embryos are
required. However, it is difﬁcult to obtain good quality
human embryos for research purposes and it is not permitted
to use human embryos for research in some countries. Hence,
most researchers use discarded human embryos from IVF
clinics. Indeed, in IVF clinics, many poor quality human
embryos have been discarded because they showed no survival
characteristics at the end of culture.
Hardarson et al. (2003) found that 58% of the embryos
produced by IVF had chromosomal abnormalities at blastocyst
stage. These abnormal embryos can be used to derive hESC
lines (Baharvand et al., 2006). However, it is still unknown
whether hESC lines with abnormal karyotypes have similar
biological characteristics and functions to those with normal
karyotypes. Therefore, in the present study, we used the
discarded embryos to establish hESC lines and then compare
the biological characteristics, imprinted gene expression,
DNA methylation and X chromosome between the hESC
lines with normal and abnormal karyotypes.
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Preparation of feeder layers
The feeder layers of murine embryonic ﬁbroblasts (MEF) were pre-
paredfrom Day13.5 post-coitumfetuses of Kunming miceas previous
described (Li et al., 2004).
Culture of human embryos
This research was approved by the ethics committee of Guangzhou
Medical College. Human embryos from IVF centers were donated
on Day 3 after the patients signed the consent. The embryos were cul-
tured in G2.3 medium (Vitrolife, Gothenburg, Sweden) until Day 5
(Kim et al., 2005). On Day 5, early blastocysts were cultured for
additional 2 days in a blastocyst optimum culture medium, which is
G2.3 medium supplemented with 2000 U/ml of human recombinant
leukemia inhibitory factor (hLIF; Chemicon, Temecula, CA, USA)
and 10 ng/ml of human basic ﬁbroblast growth factor (bFGF;
Vitrolife).
Isolation of inner cell mass
Day 7 expanded blastocysts and hatched blastocysts were used to
derive the ESC lines. Zona pellucida of expanded blastocyst was
removed by treatment with 0.1% pronase (Sigma). The inner cell
mass (ICM) of blastocysts were isolated by immunosurgery or mech-
anical method. Isolated ICMs were then placed on mitomycin
C-treated MEF feeder layers for further culture.
Culture of hESCs
After the ICMs were seeded on the feeder layer, the formation of dome
structure was examined after 8–9 days of culture. The ICMs were then
mechanically broken down into 2–3 small clumps using a small
pipette and the ICM clumps were transferred to a freshly prepared
feeder layer. These cells were again mechanically dissociated during
the initial ﬁve passages. After ﬁve passages, they were incubated in
1m g /ml collagenase IV (Invitrogen) for 20–25 min at 378C before
further culture on freshly prepared feeders. The cells were routinely
passed every 4–5 days, and the medium was changed every day.
The hESC culture medium is knockout-Dulbecco’s modiﬁed Eagle’s
medium (Gibco) supplemented with 15% serum replacement
(GIBCO), 5% deﬁned fetal bovine serum (Hyclone), 2 mM glutamine,
0.1 mM b-mercaptolethanol, 0.1 mM non-essential amino acids,
100 U/ml penicillin, 100 mg/ml streptomycin, 4 ng/ml bFGF (Invi-
trogen) and 2000 U/ml hLIF. After 10 passages, hLIF was not
added in the culture medium.
Karyotype analysis
For karyotype analysis, ESCs at passages 12, 22 and 32 were incu-
bated in the culture medium with 0.25 mg/ml colcemid (Gibco) for
4 h, then with 0.4% sodium citrate and 0.4% chloratum Kaliumat
(1:1, v/v) at 378C for 5 min, and ﬁnally were ﬁxed in methanol:acetic
acid (3:1, v/v) solution. After Giemsa staining, at least 20 cells were
examined in each group for the karyotype analysis.
Fluorescence in situ hybridization
For ﬂuorescence in situ hybridization (FISH) analysis, ESC suspen-
sions were dropped onto wet slides, dried at 638C overnight and
then dehydrated with ethanol in sequential concentrations of 70%,
85% and 100% before hybridization. FISH was performed using
Vysis MultiVysion
w PGT Multi-color Probe set (Vysis Inc., No.
32–131080), which includes ﬁve probes for chromosomes of 13, 18,
21, X and Y. The samples were stained according to recommended
FISH protocols from manufacturer and examined under a ﬂuorescence
microscope. At least, 10 cells were examined in each cell line at each
time of examination.
Staining for ESC markers
Human ESC marker staining was performed after 20 passages. To
detect alkaline phosphatase (AP) activity, ESC colonies were ﬁxed
with 90% alcohol for 2 min, washed three times with Tween-BST sol-
ution [phosphate-buffered saline (PBS) with 1% bovine serum
albumin and 0.2% Tween-20], and then stained with BCIP/NBT
(AP substrate solution, Maxim Biotech Inc., USA.) for 30 min. To
detect the hESC stage-speciﬁc embryonic markers, ESCs were ﬁxed
with 4% paraformaldehyde for 30 min and then incubated with 4%
goat serum for 1 h before ESC marker staining. Primary antibodies
were stage-speciﬁc embryonic antigens (SSEA)-4, SSEA-1, tumor-
rejection antigen (TRA)-1-81 and TRA-1-60 (Chemicon). All anti-
bodies were diluted 1:50 with PBS and the cells were incubated
with antibody solution at room temperature for 1 h. The cells were
washed three times with Tween-BST solution for 5 min and then incu-
bated with the secondary antibody [goat anti-mouse immunoglobulin
(Ig)G and goat anti-mouse IgM, both 1:100 dilution] conjugated to ﬂu-
orescein isothiocyanate for 30 min. Negative controls were carried out
without the addition of the primary antibodies. Hoechst 33342 was
used for nuclear staining. The cells were then washed again and exam-
ined under a ﬂuorescence microscope or confocal microscope.
Oct-4 expression
Total RNA was puriﬁed using Trizol Kit (Invitrogen) and RT–PCR
reaction was carried out using Qiagen One Step for RT–PCR Kit
(Qiagen, Germany) according to manufacturer’s instructions.
Octamer binding protein 4 (Oct-4) primers were used (Table I).
RT–PCR was carried out by reverse transcription for 30 min at
508C, initial PCR activation for 15 min at 958C, followed by 30
cycles of denaturation for 1 min at 948C, annealing for 1 min at
548C and ﬁnally extension for 1 min at 728C. The PCR ampliﬁed
Table I. RT–PCR and methylation-speciﬁc PCR primer sequences.
Gene Primer forward 50-30 Primer reverse50-30 Size (bp)
Oct-4 GTGTTCAGCCAAAAGACCATC CCCTGAGAAAGGAGACCCA 387
H19 CCGGACACAAAACCCTCTAGCT TGTTCCGATGGTGTCTTTGATG 142
IGF2 TCCCCTGATTGCTCTACCCA GCAGTTTTGCTCACTTCCGATT 86
SNRPN TGGCACCTTTAAGGCTTTTG CCG CTTTTCTTCACGCTCT 112
GNAS CAGCACTGCCAGTGGAGATG TGTCACGGCAGTCGTTGAAC 101
GAPD GGAGTCAACGGATTTGGTCG CCTGGAAGATGGTGATGGG 218
SNRPN-M TAAATAAGTACGTTTGCGCGGTC AACCTTACCCGCTCCATCGCG 177
SNRPN-P GTAGGTTGGTGTGTATGTTTAGGT ACATCAAACATC TCC AACAACCA 100
Oct-4, octamer binding protein 4; IGF2: insulin-like growth factor; SNRPN, small nuclear ribonucleoprotein polypeptide N; GAPD, glyceraldehyde-3-phosphate
dehydrogenase; SNRPN-M, used to analyze methylated status; SNRPN-P, used to analyze unmethylated sites.
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dium bromide (Invitrogen) staining.
DNA ﬁngerprinting and HLA typing
Total DNA was extracted using Qiagen DNeasy Tissue Kit (Qiagen)
according to manufacturer’s instructions. Extracted DNA was ampli-
ﬁed for 16 different genetic loci using the Promega PowerPlex 16
System kit (Promega, USA). Capillary electrophoresis was carried
out on an automated ABI 3100 Genetic Analyzer (Applied Biosys-
tems). The 16 short tandem repeat (STR) loci were D3S1358, TH01,
D21S11, D18S51, Penta E, D5S818, D13S317, D7S820, D16S539,
CSF1PO, Penta D, amelogenin, vWA, D8S1179, TPOX and FGA.
HLA typing was performed by PCR with sequence speciﬁc primers
(Biotest, Landsteinerstr, Dreieich Germany, Biotest HLA SSP Kit
http://www.biotest.de). The products were identiﬁed using agarose
gel electrophoresis followed by the detection of the DNA bands in
UV light with the aid of the Biotest SSP typing software to determine
the HLA-A, HLA-B and HLA-DR loci. All manipulations were per-
formed according to manufacturer’s recommendations.
Differentiation assessment in vitro
The ESC colonies were dissociated with 1 mg/ml collagenase IV and
cultured in culture plates to prevent attachment of the cells. After
culture for 3 days, the cells were transferred to a new culture plate.
Seven days after culture, the formation of embryoid bodies (EBs)
was examined. EBs were transferred to 0.1% gelatin-coated culture
dish for spontaneous differentiation. The differentiated cells were
stained with antibodies against human smooth muscle actin, cardiac
troponin I, alpha fetoprotein and nestin (Chemicon). The EB culture
medium was the same as hESC culture medium but without bFGF
and hLIF.
Differentiation assessment in vivo
The ESC colonies of passage 15 or beyond were harvested and were
broken down into 300–400 small ESC colony suspension. The colo-
nies were injected into inguinal groove of 6-week-old male severe
combined immunodeﬁciency (SCID) mice. Twelve weeks later, the
resultant tumors were removed, ﬁxed in 4% paraformaldehyde and
embedded in parafﬁn. Sections were prepared, stained with hemat-
oxylin and eosin, and examined for the presence of tissues derived
from the three germ layers.
Analysis of imprinted genes in undifferentiated hESCs
In order to identify the imprinted gene expression in undifferentiated
hES cells, total RNA was extracted from different hESC lines. Gene
expression pattern in undifferentiated cells was proﬁled using the
QIAGENE one step RT–PCR kit. Selected imprinted genes were
H19, insulin-like growth factor (IGF)2, small nuclear ribonucleopro-
tein polypeptide N (SNRPN) and the conditional gene GNAS
(Table I). The PCR was performed using 508C for 30 min, 958C for
15 min and followed by 948C for 30 s, 558C for 30 s and 728C for
45 s for 45 cycles and 728C for 5 min (Sun et al., 2006). The PCR pro-
ducts were analyzed by 2% polyacrylamide gel electrophoresis,
stained with ethidium bromide and documented using the BioImaging
system (UVP, Upland, CA, USA). Glyceraldehyde-3-phosphate
dehydrogenase served as a ubiquitously expressed control. Genomic
contamination was ruled out by including an RT-negative sample in
each PCR set as a control.
DNA methylation analysis
Methylation patterns of the imprint control (IC) region of the human
SNRPN-gene (Table I) were studied in the undifferentiated hESCs.
Four hESC lines, FY-hESC-1 (46, XY), -5 (unbalanced Robertsonian
translocations), -8 (46, XX) and FY-3PN (69, XXX), were analyzed.
Prader–Willi syndrome (PWS) and Angelman syndrome (AS)
patients as well as normal DNA samples were also analyzed by
using methylation-speciﬁc PCR (MSP) assay (Kubota et al., 1997).
Genomic DNA was extracted according to the manufacturer’s
instructions (QIAamp DNA Blood Mini Kit). The PCR products
were analyzed by 7% polyacrylamide gel electrophoresis.
X chromosome inactivation status
Human androgen receptor gene contains a highly polymorphic trinu-
cleotide repeat in the ﬁrst exon. It has been found that the methylation
of HpaII and HhaI sites ,100 bp away from this polymorphic STR
correlates with X inactivation. MSP was used to determine the methyl-
ation status of the selected sample with XX chromosome (FY-hES-5,
-7, -8 and FY-3PN). Genomic DNA was extracted from the XX hESC
lines. Two sets of PCR were prepared. One was for methylated X
alleles and the other was for unmethylated alleles. MSP primers
were Primer ARM-F 50-GCG AGC GTA GTA TTT TTC GGC-30,
Primer ARM-R 50-AAC CAA ATA ACC TAT AAA ACC TCT
ACG-30, Primer ARU-F 50-GTT GTG AGT GTA GTA TTT TTT
GGT-30 and Primer ARU-R 50-CAA ATA ACC TAT AAA ACC
TCT ACA-30. Ampliﬁcation and gel analysis were performed as man-
ufacturer’s instruction. Bisulﬁte-converted CpGenome Universal
Methylated DNA (Chemicon http://www.chemicon.com) and
bisulﬁte-converted female human blood DNA were used as positive
controls. Sample tubeswere loaded to Genetic Analyzer 310 for analy-
sis of fragmentation. The size of PCR products of the androgen recep-
tor gene was between 177 and 221 bp (Kubota et al., 1999).
Results
Derivation of hESC lines
In this study, 265 donated embryos were used and 42 (15.8%)
developed to early blastocysts on Day 5 (Fig. 1I, A). When
these early blastocysts were transferred to blastocyst
optimum culture medium for another 2 days, 36 developed to
expanded blastocysts and 6 to hatched blastocysts. A total of
42 ICMs (Fig. 1I, B) were isolated using immunosurgery (19
ICM) or mechanical method (23 ICM). All ICMs were
seeded on MEF feeder layer (Fig. 1I, C-H).
Seven hESC lines have been established in our laboratory
(16.7% of the blastocysts or 2.6% of Day 3 embryos). After
nine passages, cells at various passages were frozen and
thawed to examine the survival status and were found to
survive in the subsequent cultures. FY-hES-1 has been in con-
tinuous culture for 1 year and 76 passages, whereas FY-3PN,
FY-hES-3, -4, -5, -7 and -8 have been in continuous cultures
for 44, 38, 30, 27, 20 and 15 passages, respectively (Table II).
Characterization and identiﬁcation of hESC lines
Cells in all seven lines showed a high level of AP activity and
strongly expressed TRA-1-60, TRA-1-81 and SSEA-4
(Fig. 1II, A, D, E and C, respectively) but not SSEA-1 proteins
(Fig. 1II, B). Oct-4 mRNA expression was observed in all
seven hESC lines (Fig. 2). Sixteen STR loci were analyzed
for hESC lines and each cell line showed distinct STR loci indi-
cating that they were derived from different embryos (Fig. 3A–
G). HLA typing also showed that the seven lines have different
HLA-A and DBR loci (Table III).
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Chromosome analysis and FISH examination showed that
FY-hES-1, -3 and -4 had normal 46, XY karyotypes,
FY-hES-7 and -8 had normal 46, XX karyotypes, FY-3PN
had 69, XXX karyotype (Fig. 4A–F), whereas FY-hES-5 was
an unbalanced Robertsonian translocations with 46, XX,þ13,
der(13;13)(q10;q10) (Fig. 4G) irrespective of the passages
12, 22 and 32. As shown in Fig. 4H, FISH images of
FY-hES-5 at the 22 passage showed three chromosome 13
(red signals), 2 chromosome 18 (aqua), 2 chromosome 21
(green), 2 X chromosome (blue) and no Y chromosome after
ﬁve probe staining, which was the same as examined in other
passages. All cells in other cell lines also maintained the
same karyotypes as original chromosomal analysis. Embryo
donor for FY-hES-5 had normal karyotype.
Differentiation of hESC lines
The cells of the hESC lines were cultured in suspension on
Petri dishes, simple EBs were formed on Day 3 and cystic
EBs on Dasy 6–7. On Day 8, these EBs were transferred to
0.1% gelatin-coated plates for further culture to examine cell
differentiation. After 4 days culture, these cells were positively
stained by antibodies against human smooth muscle actin
(mesoderm), alpha fetoprotein (endoderm) and nestin (ecto-
derm) (data not shown). Hence, all hESC lines were able to
differentiate into three germ layers in vitro. When hESCs
were injected into SCID mice, teratomas were ﬁrst observed
at 4–5 weeks and the size of teratomas reached 25   30 mm
after 12 weeks. After the teratomas were excised and sectioned
for examination, three embryonic germ layers including endo-
derm (gut epithelium), mesoderm (cartilage and muscle) and
ectoderm (squamous epithelium, neuroectoderm and neural
ganglia) were identiﬁed (Fig. 5A–D).
Analysis of imprinted genes in undifferentiated hES cells
In order to assess if there are any differences in gene expression
between normal and abnormal karyotype hESC lines, we
examined maternal expressed imprinted geneH19, paternal
expressed imprinted gene IGF2 and SNRPN and conditional
gene GNAS as disrupted expression of these genes is
associated with human genetic diseases, such as PWS and
AS. We found that gene expression patterns in all four of
these cell lines were similar. These results indicate that
expression of H19, IGF2, SNRPN and GNAS in the abnormal
karyotype hESC lines were regulated in a similar way as in the
normal ESC lines (Fig. 6).
DNA methylation
The SNRPN is a paternally expressed imprinted gene that is
located on chromosome 15q11–13, a region related to PWS
and AS. The IC-region of the SNRPN-gene showed 23
CpG-sites that are methylated on the maternal chromosome
and unmethylated on the paternal chromosome (Zeschnigk
et al., 1997). Genomic sequencing of the SNRPN region after
bisulﬁte treatment has revealed that .96% of all CpG dinu-
cleotides are methylated on the maternal chromosome, but
none on the paternal chromosome. A normal person or
normal hESCs have both methylated and unmethylated
SNRPN gene sites. In this study, two pairs of primers were
used to analyze SNRPN gene methylation status. Primer
SNRPN-M was used to analyze methylated status (174 bp
band) and primer SNRPN-P was used to analyze unmethylated
sites (100 bp band). Normal and abnormal karyotype hESC
lines showed both 100 and 174 bp bands. MSP analysis
Figure 1: Derivation of hESC lines and characteristics.
(I) Human embryos and isolated ICM. (A) A Day 5 blastocyst cultured
in G2.3 blastocyst medium. Note the small ICM. (B) A Day 7 blasto-
cyst that has been cultured in the blastocyst optimum medium for
another 2 days. The ICM became clearer. (C) An ICM isolated by
mechanical method. (D) A round ICM colony surrounded by a
group of residual trophectoderm after mechanical isolation. (E) An
ICM isolated by immunosurgery. (F) A dome-like structure on the
feeder layer formed after 8 days culture of ICM isolated with immu-
nosurgery. Arrows in C to F indicate ICMs. (G) Typical round
hESC colonies with very clear boundary at low magniﬁcation. (H)
hESC morphology in a colony, showing a high nucleus–cytoplasm
ratio; note the presence of nucleoli and typical intercellular spaces
at high magniﬁcation. Bar ¼ 25 mm in A, B, C and D and
bar ¼ 100 mm in E, F and G. (II) Immunocytochemical staining of
undifferentiated hESC colonies after 32 passages in four cell lines
(A) AP, (B) SSEA-1, (C) SSEA-4, (D) TRA-1-60 and (E)
TRA-1-81. Bar ¼ 100 mm.
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methylation status (Fig. 6).
Determination of X-inactivation pattern
X-inactivation means that one of the X chromosomes is
silenced in XX female mammals. Initiation of this process
during early development is controlled by the X-inactivation
centre, a complex locus that determines how many and
which X chromosomes will be inactivated. In order to
analyze DNA methylation in XX hESC lines, MSP was used
to observe the X-inactivation status in these ESC lines
(Table II).
In a random X chromosome inactivation pattern, the XX
hESC should have two active alleles and two inactive alleles.
The peak area ratio in both active and inactive allele should
be 50:50 (the peak area ratio of the small allele to the larger
allele). However, in the present study, we found that all of
the XX hESC lines have both active and inactive X chromo-
somes with non-random inactivation patterns of either
.80:20 or ,20:80 (Fig. 7). FY-hES-5 and -8 had almost
complete non-random X chromosome inactivation patterns
with only one inactive X chromosome (194 bp in FY-hES-5
and 191 bp in FY-hES-8). The inactivation ratio in the
FY-3PN was also non-random (data not shown). In contrast,
in the normal female blood DNA samples (as a control),
there were two active (194 and 207 bp) and two inactive
(194 and 207 bp) X chromosomes with a random X chromo-
some inactivation pattern of 50:50. The XY hESC line
(FY-hES-1) always had one active X chromosome (197 bp)
but did not have inactive X chromosome (Fig. 7).
Table II. Human embryonic stem cell (hESC) lines and their characteristics.
hESC lines FY-hES-1 FY-hES-3 FY-hES-4 FY-hES-5 FY-hES-7 FY-hES-8 FY-3PN
Karyotypes 46, XY 46, XY 46, XY 46, XX, þ13,der
(13;13) (q10;q10)
46, XX 46, XX 69,XXX
AP activity þþþþ þþþ
SSEA-4 þþþþ þþþ
SSEA-1 2222 222
TRA-1-81 þþþþ þþþ
TRA-1-60 þþþþ þþþ
STR þþþþ þþþ
HLA typing þþþþ þþþ
FISH analysis þþþþ þþþ
Embryoid in vitro þþþþ þþþ
Teratomas in vivo þþþþ þþþ
Imprinted genes
pppp ppp
DNA methylation
p
N/AN /A
pp
N/A
p
X chromosome status
p
N/AN /A
p ppp
No. of Passages 76 38 30 27 20 15 44
AP, alkaline phosphatase; SSEA, stage-speciﬁc embryonic antigen; TRA, tumor-rejection antigen; STR, short tandem repeat; FISH, ﬂuorescence in-situ
hybridization; “
p
” indicates that the samples were analyzed; N/A, not applicable (not analyzed).
Figure 2: Octamer binding protein 4 expression by RT–PCR.
Lanes 3–9 represent FY-hES-1, -3, -4, -5, -7, -8 and FY-3PN, respec-
tively. Lane 1 is a negative control and lane 2 is human b-actin
(265 bp).
Figure 3: DNA ﬁngerprinting of FY-hES-1 (A), -3 (B), -4 (C), -5 (D), -7 (E), -8 (F) and -3PN (G), respectively.
Characteristics of human embryonic stem cells
2189Discussion
In the present study, ﬁve hESC lines with normal karyotypes
and two lines with abnormal karyotypes have been derived
from poor quality blastocysts. Successful derivation of hESC
lines from poor quality blastocysts has been previously
reported by other authors (Hovatta et al., 2003; Mitalipova
et al., 2003; Genbacew et al., 2005; Chen et al., 2005; Mateizel
et al., 2006; Lerou et al., 2008): the derivation rate from poor
quality blastocysts was ,10%. In the present study, out of 42
blastocysts, seven ESC lines have been established with a rate
of 16.7%. This higher rate may be attributed to the further
culture of Day 5 blastocysts in the blastocyst optimum
culture medium, which signiﬁcantly increased the number of
cells in the ICM, thus isolation of ICM became much easier.
However, if the rate is calculated from Day 3 embryos, it is
very low (2.6%) in the present study. This rate is the same as
that reported previously (Chen et al., 2005; Genbacew et al.,
2005). The low rate is due to poor quality of Day 3 embryos
as many of them usually arrest during the subsequent culture
due to chromosome abnormalities, such as aneuploidy, mosai-
cism, haploidy or polyploidy, as these are often found in poor
human embryos (Magli et al., 2007; Munne et al., 2007).
Currently, there are standard culture protocols for human
ESC culture and there are many poor quality human embryos
being discarded from IVF clinics. Thus, if these embryos can
be used correctly, it is possible to establish more and more
hESC lines.
We also established two ESC lines with abnormal chromoso-
mal constitution (FY-hESC-5) and three pronucleus (FY-3PN)
embryos. Some hESC lines with abnormal chromosomal con-
stitution have also been derived previously (Draper et al.,
2004; Heins et al., 2004; Munne et al., 2005; Verlinsky
et al., 2005; Baharvand et al., 2006). Munne et al. (2005)
reported that ESCs derived from trisomic embryos can
undergo self-correction, partially or totally, to chromosomally
normal cells, thus they observed mosaic in their hESCs.
However, we did not observe such self-correction in the
present study.
There are two possibilities for the origins of cell lines with
normal karyotype. One is that it is derived from normal ferti-
lized oocytes, thus all chromosomes are normal in the sub-
sequent culture, and the other is that it is derived from
embryos with chromosomal abnormalities, but the cells
Table III. HLA typing of FY-hESC lines.
HLA type A B DRB
FY-hES-1 A2/A2 B46/B60 DR9/DR16
FY-hES-3 A11/A11 B46/B46 DR9/DR11
FY-hES-4 A2/A2 B46/B54 DR9/DR10
FY-hES-5 A11/A29 B7/B54 DR10/DR13
FY-hES-7 A11/A24 B35/B35 DR14/DR15
FY-hES-8 A11/A33 B13/B58 DR9/DR16
FY-3PN A11/A33 B44/B58 DR17/DR10
Figure 4: Karyotypes of hESC lines.
Karyotype analysis (A–G) and FISH images (H) of hESC. Normal 46, XY karyotypes of FY-hES-1 (A), -3 (B) and -4 (C), normal 46, XX of
FY-hES-7 (D) and -8 (E). FY-3PN (F) shows a triploid karyotype of 69, XXX. FY-hES-5 (G) shows unbalanced Robertsonian translocations
with 46, XXþ13, der (13;13) (q10;q10) karyotype. Blue arrow indicates duplicate chromosome 13. FISH of interphase nuclei from FY-hES-5
cells shows two chromosome 13 (red), two chromosome 21 (green), two chromosome 18 (aqua) and two X chromosomes (blue) (H).
Sun et al.
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chromosomes are normal in the cell lines. In the present
study, because we did not examine the embryo’s chromosomal
constitutions at Day 3 or 5, we do not know if the cell lines with
normal karyotype are derived from embryos with normal
chromosomes or embryos with chromosomal abnormalities.
In the present study, self-correction was not observed in a
hESC line (FY-3PN) that was derived from a triploid
embryo. Triploid embryos used for hESC line derivation may
be from a polyspermic oocyte or a diploid oocyte plus a ferti-
lized sperm. In the present study, when we further examined
STRs in this cell line, we found that it was a homogeneous tri-
ploid cell line (the peak area ratio of each STR locus except
D7S820 is almost 1:2.) (Fig. 3G). Therefore, this cell line
may result from duplication of the chromosomes in the
oocyte. No mosaic in the chromosomal constitutions may
indicate that the chromosomes are more stable in the cell
lines derived from such triploid embryos than trisomy
embryos.
Also, in the unbalanced Robertsonian translocation cell line,
the two long arms of 13 chromosomes fused at the centromere
and the two short arms were lost. This situation is also different
from chromosome separation error in the aneuploid embryo.
Thus, it may be difﬁcult to self-correct such an error. From
these results, it would appear that self-correction occurs in the
ESCs derived from partial chromosomally abnormal embryos,
but not in the ESC lines derived from complete triploid
embryos or translocation embryos. It is also possible that
somecelllinesmayundergoself-correction,butothersmaynot.
Previous studies indicated that hESC from chromosomally
abnormal embryos had all cell markers that hESC should
have, and had the ability to differentiate (Heins et al., 2004;
Baharvand et al., 2006). In the present study, we examined
not only cell markers and ability to differentiate, but also
other characteristics, such as imprinted genes, DNA methyl-
ation and X chromosome inactivation. Similar to previous
studies, we did not ﬁnd any difference in all characteristics in
all seven lines, such as AP activity and cell surface markers,
SSEA-4, TRA-1-60 and TRA-1-81. Oct-4, which is an import-
ant factor for early embryos and undifferentiated cells (Hay
et al., 2004: Lee et al., 2006), was present in all cell lines.
Furthermore, all of these hESC lines are pluripotent. When
the cells were injected into immunosuppressed mice to
examine the formation of teratomas, we found that they
formed cells of all three germ layers including mesoderm (car-
tilage), ectoderm (epithelium) and endoderm (muscle cells).
Also when these cells were spontaneously differentiated in
vitro, EBs formed muscular cells, nerve cells and other types
of cells.
In order to practically use the established hESCs, the charac-
teristics of each cell line should be clariﬁed. Therefore, we
developed a comprehensive database of DNA proﬁles for
each cell line based on STR loci and HLA typing. The exploi-
tation of STR elements in the genome is important in the ﬁeld
of genetic mapping, linkage analysis and human identity
testing. STR loci have become the standard for identifying
hESC lines (Plaia et al., 2006). STR analysis is also useful in
conﬁrming and clarifying some of the anomalies. For
Figure 7: X chromosome inactivation analysis of the XX hESC line.
Column A represents inactive X chromosome and column B rep-
resents active X chromosome. A normal female blood DNA and
FY-hES-1 (46, XY) was used as a control (red peak is the marker
and blue peak is the product).
Figure 6: RT–PCR analysis of imprinted gene expression (left
panel).
Paternally expressed gene IGF2, small nuclear ribonucleoprotein
polypeptide N (SNRPN) and maternally expressed gene H19 were
analyzed in fourhESC lineswith differentkaryotypes. Theconditional
gene GNAS was used as an additional control. Glyceraldehyde-3-
phosphate dehydrogenase (GAPD) was included as mRNA quantitat-
ive control. SNRPN gene methylation status (right panel) in
FY-hES-1, -5, -7, and -3PN lines, AS, PWS and normal DNA was
used as control.
Figure 5: Histology analysis of teratomas derived from FY-hES-1
and FY-3PN hESC lines.
(A) Squamous epithelium tissue from ectoderm; (B) neural ganglia
tissue from ectoderm; (C) cartilage tissue from mesoderm and (D)
glandular tissue from endoderm.
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when compared with others. In order to provide more major
histocompatibility complex matched cell lines, HLA typing
would be critical for stem cell-based therapies. HLA is a
family of cell proteins found on the surface of white blood
cells and other nucleated cells in the body. These proteins
vary from person to person and are critical for the activation
of immune responses. HLA-matched transplantation will mini-
mize the possibility of rejection. Our results from seven cell
lines revealed that all of these cells were heterozygous HLA
genotype.
Epigenetic stability has profound implications for the use of
hESCs in regenerative medicine. Genomic imprinting is erased
in the primordial germ cells during development and is reestab-
lished during gametogenesis. Aberrant expression of imprinted
genes can cause inherited diseases and induce tumors. For
example, the imprinting domain on human chromosome
15q11–13 contains a large cluster of imprinted genes, includ-
ing paternally expressed SNRPN. Improper regulation of
imprinted genes in this cluster results in PWS and AS (Glenn
et al., 1997). Loss of imprinting of H19 gene or IGF2 gene,
which is normally located at 11p15.5, is related to embryonic
cancers, such as BWS [Beckwith–Wiedemann syndrome and
Wilm’s tumor, Neu-roblastomas and Yolk sac carcinomas
(Rainier et al., 1995)]. In our study, no different expression
in H19, IGF2, SNRPN and GNAS was found in these cell lines.
DNA methylation is essential for normal mammalian devel-
opment (Herman et al., 1996). It is not clear whether the poten-
tial epigenetic changes occur during long-term ESC culture.
Thus, in order to reveal epigenetic stability of imprinted
genetic regions of SNRPN in undifferentiated hES cells, we
examined DNA methylation status via MSP (Zeschnigk
et al., 1997). The SNRPN critical region, such as the maternal
allele, is methylated and the paternal allele is not methylated
and is transcriptionally active. MSP analysis of these regions
demonstrated that all of the hESCs have a normal SNRPN
methylation status, indicating that there are no deletions, uni-
parental disomy or imprinting mutations of SNRPN methyl-
ation in these normal and abnormal karyotype hESC lines.
In mice, establishing a stable XX ESC line is not easy due to
loss of one X chromosome. The unstable X chrosomosome
and DNA methylation have been found in diploid parthenoge-
netic ESC lines, which results in only one X chromosome (XO
genotype) in the cells (Robertson et al., 1983; Zvetkova et al.,
2005). Failures of X chromosome inactivation in different
hESC lines has also been reported (Dhara and Benvenisty,
2004; Hoffman et al., 2005). Epigenetic variation between
hESC lines may also perturb X chromosome inactivation. In
order that female embryos express similar levels of X-linked
genes to males, one of the two X chromosomes is inactivated
at an early embryonic stage. It has been revealed by genetic
studies that X chromosome selection is inﬂuenced by the X
controlling element (Simmler et al., 1993). The X chromosome
is randomly inactivated in a 50:50 ratio in most females
whereas  10% females have a non-random X chromosome
inactivation (Kubota et al., 1999). Asymptomatic female car-
riers of X-linked diseases have the preferential selection of
the normal non-mutated X chromosome, which causes
extremely non-random inactivation, such as X-linked hyper-
IgM syndrome (97:3), Pai syndrome (89:11), multiple congen-
tial anomalies (4:96) and unbalanced X autosome translocation
(91:9) (Kubota et al., 1999). Therefore, determination of the X-
inactivation pattern is important for the detection of carriers of
X-linked diseases. Our data showed that all of our XX hESC
lines have both active and inactive X chromosomes. Almost
extremely non-random X chromosome inactivation patterns
(.95:5) were also found in FY-hES-5, FY-hES-8 and
FY-3PN. Our data indicate that the patterns of XX hESC
with extremely non-random X chromosome inactivation are
similar to the patterns of X-linked diseases with skewed X
chromosome inactivation. Whether this phenotype means a
relationship between XX hESC lines and X-linked disease is
unknown, thus further study on the mechanism of non-random
X inactivation may be necessary to explain epigenetic states
and developmental competence in hESC lines. X chromosome
inactivation should be affected in the hESC lines derived from
triploidy embryos since there were three X chromosomes.
However, we did not ﬁnd signiﬁcant differences in X chromo-
some inactivation in the cell line with XX chromosomes and
three X chromosomes. Further studies are necessary to
address these issues and hESC lines with abnormal karyotypes
are useful materials for these studies.
In conclusion, our results indicate that new hESC lines can
be successfully established from poor quality human
embryos. All hESC lines established in our laboratory
showed all hESC characteristics and could be differentiated
into three germ layers, regardless of their karyotype. Through
the detailed examination of ESC biological characterizations,
gene expression, DNA methylation and X-inactivation, we
found that hESC lines with abnormal karyotype are also
useful experimental materials for developmental biology and
genetic research. Our results also indicate that these ESC
lines have potential application in human cell therapy.
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